Armata Pharmaceuticals (ARMP) Prepaid Assets (2013 - 2026)
Armata Pharmaceuticals (ARMP) posted Prepaid Assets of $47000.0 for Q1 2026, down 96.88% sequentially from $1.5 million in Q4 2025, and down 80.25% YoY from $238000.0 in Q1 2025.
Armata Pharmaceuticals (ARMP) Prepaid Assets (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Prepaid Assets for 14 years, with the latest figure at $47000.0 in Q1 2026.
- Quarterly Prepaid Assets fell 80.25% year-over-year to $47000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47000.0 (down 80.25% YoY) and the FY2025 annual result came in at $1.5 million, up 102.69% from the prior year.
- Prepaid Assets slipped to $47000.0 in Q1 2026 per ARMP's latest filing, from $1.5 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $12.2 million in Q1 2023 and troughed at $47000.0 in Q1 2026.
- A 5-year average of $3.4 million and a median of $2.3 million in 2023 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets soared 1059.43% in 2023, then slumped 86.11% in 2025.
- Over 5 years, Prepaid Assets stood at $3.7 million in 2022, then slumped by 38.18% to $2.3 million in 2023, then tumbled by 67.15% to $744000.0 in 2024, then surged by 102.69% to $1.5 million in 2025, then plunged by 96.88% to $47000.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $47000.0, $1.5 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Armata Pharmaceuticals | 182.82 Mn | 158.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.53 Mn |
| Mar 31, 2026 | 47,000.00 |
| Dec 31, 2025 | 1.51 Mn |
| Sep 30, 2025 | 1.42 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 238,000.00 |
| Dec 31, 2024 | 744,000.00 |
| Sep 30, 2024 | 3.03 Mn |
| Jun 30, 2024 | 3.26 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 2.27 Mn |
| Sep 30, 2023 | 8.50 Mn |
| Jun 30, 2023 | 8.63 Mn |
| Mar 31, 2023 | 12.23 Mn |
| Dec 31, 2022 | 3.66 Mn |
| Sep 30, 2022 | 6.00 Mn |
| Jun 30, 2022 | 2.45 Mn |
| Mar 31, 2022 | 1.06 Mn |
| Dec 31, 2021 | 1.72 Mn |
| Sep 30, 2021 | 851,000.00 |